Slingshot Insights | Marathon Pharmaceuticals Overview

MARATHON PHARMACEUTICALS Overview

Upcoming Projects (MARATHON PHARMACEUTICALS)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (MARATHON PHARMACEUTICALS)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (MARATHON PHARMACEUTICALS)

PTCT Acquires Duchenne Muscular Dystrophy Drug (DMD) Emflaza (Deflazacort) from Marathon Pharmaceuticals
Tickers: PTCT, Marathon Pharmaceuticals
Occurred on: Mar 16, 2017
FDA Accepts Marathon Pharmaceuticals’ New Drug Applications for Deflazacort for the Treatment of Duchenne Muscular Dystrophy and Grants Priority Review
Ticker: MARATHON PHARMACEUTICALS
Occurred on: Aug 10, 2016
Marathon Pharmaceuticals Announces Submission of Deflazacort New Drug Application to the FDA
Ticker: MARATHON PHARMACEUTICALS
Occurred on: Jun 14, 2016

Strategic Initiatives (MARATHON PHARMACEUTICALS)

Don’t see a strategic initiative related to the company you care about? Create your own!